A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We are honored to provide technology and services to help providers thrive, and that the HFMA panel awarded our solution Peer Review designation.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Seven of Premier’s most pioneering healthcare suppliers, their products and the ways that they're helping to improve the health of communities will be celebrated.
Premier data highlights three key factors that contributed to recent drug shortages.
Value-based care can help give providers flexibility to innovate care and holds them accountable for clinical outcomes and cost of treating an entire population.
Automated buying experience with complete visibility into procurement will help drive healthcare supply chain resiliency, savings opportunities and quality patient care across the care continuum.
PINC AI™ Stanson developed four tools that offer an appealing alternative to streamline the burdensome prior authorization process.
Premier weighs in on the framework for the Digital Health Technologies in Drug and Biological Product Development.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
Premier's Karen Niven highlights the essential role of change management in successful healthcare value analysis programs.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.